Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jeff Jones's Stock Ratings
Oppenheimer Analyst
Jeff Jones is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/04/2025
Overall Average Return
-19.9%
Smart Score
Overall Average Return Percentile
11th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/27/2025 | KYMR | Buy Now | Kymera Therapeutics | $44.79 | 18.33% | Jeff Jones35% | $56 → $53 | Maintains | Outperform | Get Alert |
| 06/24/2025 | AVBP | Buy Now | ArriVent BioPharma | $20.77 | 111.84% | Jeff Jones35% | $39 → $44 | Maintains | Outperform | Get Alert |
| 05/29/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.30 | 248.84% | Jeff Jones35% | $20 → $15 | Maintains | Outperform | Get Alert |
| 05/16/2025 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | 747.46% | Jeff Jones35% | $11 → $10 | Maintains | Outperform | Get Alert |
| 05/15/2025 | ALMS | Buy Now | Alumis | $3.35 | 646.27% | Jeff Jones35% | $26 → $25 | Maintains | Outperform | Get Alert |
| 05/14/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.30 | 365.12% | Jeff Jones35% | $21 → $20 | Maintains | Outperform | Get Alert |
| 05/09/2025 | ZURA | Buy Now | Zura Bio | $1.18 | 1340.68% | Jeff Jones35% | $19 → $17 | Maintains | Outperform | Get Alert |
| 05/09/2025 | CRVS | Buy Now | Corvus Pharma | $3.93 | 332.57% | Jeff Jones35% | $15 → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 05/08/2025 | IMCR | Buy Now | Immunocore Holdings | $33.02 | 160.45% | Jeff Jones35% | $85 → $86 | Maintains | Outperform | Get Alert |
| 05/07/2025 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 623.51% | Jeff Jones35% | $60 → $56 | Maintains | Outperform | Get Alert |
| 03/26/2025 | ZURA | Buy Now | Zura Bio | $1.18 | 1510.17% | Jeff Jones35% | $20 → $19 | Maintains | Outperform | Get Alert |
| 03/26/2025 | CRVS | Buy Now | Corvus Pharma | $3.93 | 281.68% | Jeff Jones35% | $14 → $15 | Maintains | Outperform | Get Alert |
| 01/30/2025 | ALMS | Buy Now | Alumis | $3.35 | 855.22% | Jeff Jones35% | → $32 | Initiates | → Outperform | Get Alert |
| 01/24/2025 | EVH | Buy Now | Evolent Health | $11.87 | 51.7% | Jeff Jones35% | $28 → $18 | Maintains | Outperform | Get Alert |
| 12/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $4.88 | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/22/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | $22 → $16 | Maintains | Outperform | Get Alert |
| 11/19/2024 | CLRB | Buy Now | Cellectar Biosciences | $4.88 | 145.9% | Jeff Jones35% | $14 → $12 | Maintains | Outperform | Get Alert |
| 11/18/2024 | EVH | Buy Now | Evolent Health | $11.87 | 135.97% | Jeff Jones35% | $34 → $28 | Maintains | Outperform | Get Alert |
| 11/18/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.30 | 434.88% | Jeff Jones35% | → $23 | Initiates | → Outperform | Get Alert |
| 11/15/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | 832.2% | Jeff Jones35% | $13 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 11/13/2024 | CRVS | Buy Now | Corvus Pharma | $3.93 | 256.23% | Jeff Jones35% | $8 → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 341.18% | Jeff Jones35% | $10 → $9 | Reiterates | Outperform → Outperform | Get Alert |
| 11/08/2024 | EVH | Buy Now | Evolent Health | $11.87 | 186.54% | Jeff Jones35% | $45 → $34 | Maintains | Outperform | Get Alert |
| 10/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $4.88 | 186.89% | Jeff Jones35% | $14 → $14 | Reiterates | Outperform → Outperform | Get Alert |
| 10/11/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 09/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $44.79 | 25.03% | Jeff Jones35% | $52 → $56 | Maintains | Outperform | Get Alert |
| 09/10/2024 | AVBP | Buy Now | ArriVent BioPharma | $20.77 | 87.77% | Jeff Jones35% | $35 → $39 | Reiterates | Outperform → Outperform | Get Alert |
| 08/15/2024 | AVBP | Buy Now | ArriVent BioPharma | $20.77 | 68.51% | Jeff Jones35% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
| 08/13/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | $19 → $17 | Maintains | Outperform | Get Alert |
| 08/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $33.02 | 169.53% | Jeff Jones35% | $87 → $89 | Reiterates | Outperform → Outperform | Get Alert |
| 08/08/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.29 | 3388.37% | Jeff Jones35% | $48 → $45 | Maintains | Outperform | Get Alert |
| 08/07/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 1036.95% | Jeff Jones35% | $80 → $88 | Maintains | Outperform | Get Alert |
| 07/10/2024 | KYMR | Buy Now | Kymera Therapeutics | $44.79 | 16.1% | Jeff Jones35% | $52 → $52 | Maintains | Outperform | Get Alert |
| 07/10/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 933.59% | Jeff Jones35% | $80 → $80 | Reiterates | Outperform → Outperform | Get Alert |
| 06/18/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | — | Reiterates | Outperform → Outperform | Get Alert |
| 06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $11.87 | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/06/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 390.2% | Jeff Jones35% | $12 → $10 | Maintains | Outperform | Get Alert |
| 06/03/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 933.59% | Jeff Jones35% | $60 → $80 | Maintains | Outperform | Get Alert |
| 05/10/2024 | ZURA | Buy Now | Zura Bio | $1.18 | 1679.66% | Jeff Jones35% | $16 → $21 | Maintains | Outperform | Get Alert |
| 05/09/2024 | MCRB | Buy Now | Seres Therapeutics | $11.87 | -66.3% | Jeff Jones35% | $5 → $4 | Maintains | Outperform | Get Alert |
| 05/08/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 675.19% | Jeff Jones35% | $58 → $60 | Maintains | Outperform | Get Alert |
| 05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.29 | 3620.93% | Jeff Jones35% | $47 → $48 | Reiterates | Outperform → Outperform | Get Alert |
| 05/07/2024 | CRVS | Buy Now | Corvus Pharma | $3.93 | 103.56% | Jeff Jones35% | $7 → $8 | Maintains | Outperform | Get Alert |
| 05/06/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | 408.47% | Jeff Jones35% | → $6 | Upgrade | Perform → Outperform | Get Alert |
| 05/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $44.79 | 16.1% | Jeff Jones35% | $53 → $52 | Maintains | Outperform | Get Alert |
| 04/22/2024 | KYMR | Buy Now | Kymera Therapeutics | $44.79 | 18.33% | Jeff Jones35% | → $53 | Initiates | → Outperform | Get Alert |
| 04/01/2024 | ZURA | Buy Now | Zura Bio | $1.18 | 1255.93% | Jeff Jones35% | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | $1.2 → $1.5 | Reiterates | Outperform → Outperform | Get Alert |
| 04/01/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | — | Jeff Jones35% | — | Reiterates | Perform → Perform | Get Alert |
| 03/28/2024 | CLRB | Buy Now | Cellectar Biosciences | $4.88 | 145.9% | Jeff Jones35% | $11 → $12 | Reiterates | Outperform → Outperform | Get Alert |
| 03/20/2024 | CRVS | Buy Now | Corvus Pharma | $3.93 | 78.12% | Jeff Jones35% | $8 → $7 | Maintains | Outperform | Get Alert |
| 03/19/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | $1.2 → $1.2 | Reiterates | Outperform → Outperform | Get Alert |
| 03/13/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 649.35% | Jeff Jones35% | $51 → $58 | Reiterates | Outperform → Outperform | Get Alert |
| 03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 488.24% | Jeff Jones35% | → $12 | Upgrade | Perform → Outperform | Get Alert |
| 03/08/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | — | Jeff Jones35% | — | Maintains | Perform | Get Alert |
| 03/06/2024 | MCRB | Buy Now | Seres Therapeutics | $11.87 | -57.88% | Jeff Jones35% | $9 → $5 | Maintains | Outperform | Get Alert |
| 03/01/2024 | EVH | Buy Now | Evolent Health | $11.87 | 279.24% | Jeff Jones35% | → $45 | Initiates | → Outperform | Get Alert |
| 02/29/2024 | PDCO | Buy Now | Patterson Cos | — | — | Jeff Jones35% | $32 → $30 | Maintains | Neutral | Get Alert |
| 02/21/2024 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | — | Jeff Jones35% | — | Reiterates | → Perform | Get Alert |
| 02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 01/29/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 558.91% | Jeff Jones35% | $20 → $51 | Maintains | Outperform | Get Alert |
| 01/16/2024 | MCRB | Buy Now | Seres Therapeutics | $11.87 | -24.18% | Jeff Jones35% | $10 → $9 | Maintains | Outperform | Get Alert |
| 01/05/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones35% | $13 → $15 | Maintains | Outperform | Get Alert |
| 12/27/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones35% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 11/30/2023 | PDCO | Buy Now | Patterson Cos | — | — | Jeff Jones35% | $35 → $32 | Maintains | Neutral | Get Alert |
| 09/29/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones35% | → $13 | Initiates | → Outperform | Get Alert |
| 08/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.29 | 3931.01% | Jeff Jones35% | $51 → $52 | Maintains | Outperform | Get Alert |
| 08/09/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 184.24% | Jeff Jones35% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
| 07/05/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 2939.22% | Jeff Jones35% | $62 → $62 | Reiterates | Outperform → Outperform | Get Alert |
| 06/22/2023 | PDCO | Buy Now | Patterson Cos | — | — | Jeff Jones35% | $31 → $35 | Maintains | Neutral | Get Alert |
| 06/07/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/01/2023 | NOVN | Buy Now | Novan | — | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/25/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.24 | 3298.47% | Jeff Jones35% | → $8 | Maintains | Outperform | Get Alert |
| 05/23/2023 | RAIN | Buy Now | Rain Oncology | $3.50 | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/19/2023 | CATX | Buy Now | Perspective Therapeutics | — | — | Jeff Jones35% | $1 → $1.2 | Maintains | Outperform | Get Alert |
| 05/16/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | Jeff Jones35% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2023 | NOVN | Buy Now | Novan | — | — | Jeff Jones35% | $9 → $8 | Maintains | Outperform | Get Alert |
| 05/11/2023 | PMVP | Buy Now | PMV Pharma | $1.24 | 1109.68% | Jeff Jones35% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
| 05/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.29 | 3853.49% | Jeff Jones35% | $44 → $51 | Maintains | Outperform | Get Alert |
| 05/10/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $7.74 | 184.24% | Jeff Jones35% | → $22 | Upgrade | Perform → Outperform | Get Alert |
| 04/18/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | 493.22% | Jeff Jones35% | $12 → $7 | Maintains | Outperform | Get Alert |
| 03/30/2023 | ANTX | Buy Now | AN2 Therapeutics | $1.05 | 2185.71% | Jeff Jones35% | $20 → $24 | Maintains | Outperform | Get Alert |
| 03/24/2023 | MBRX | Buy Now | Moleculin Biotech | $0.35 | 1333.49% | Jeff Jones35% | → $5 | Reiterates | → Outperform | Get Alert |
| 03/24/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 2939.22% | Jeff Jones35% | $65 → $62 | Maintains | Outperform | Get Alert |
| 03/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.29 | 3310.85% | Jeff Jones35% | $43 → $44 | Maintains | Outperform | Get Alert |
| 03/07/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.24 | 3298.47% | Jeff Jones35% | $10 → $8 | Maintains | Outperform | Get Alert |
| 03/02/2023 | PMVP | Buy Now | PMV Pharma | $1.24 | 1109.68% | Jeff Jones35% | $28 → $15 | Maintains | Outperform | Get Alert |
| 03/01/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones35% | $125 → $150 | Maintains | Outperform | Get Alert |
| 01/27/2023 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 2841.18% | Jeff Jones35% | $55 → $60 | Maintains | Outperform | Get Alert |
| 12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones35% | $61 → $125 | Maintains | Outperform | Get Alert |
| 11/17/2022 | EVAX | Buy Now | Evaxion Biotech | $2.38 | 362.18% | Jeff Jones35% | $16 → $11 | Maintains | Outperform | Get Alert |
| 10/11/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Jeff Jones35% | → $20 | Initiates | → Outperform | Get Alert |
| 10/04/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones35% | $50 → $65 | Maintains | Outperform | Get Alert |
| 09/12/2022 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 3086.27% | Jeff Jones35% | $40 → $65 | Maintains | Outperform | Get Alert |
| 08/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 1860.78% | Jeff Jones35% | $30 → $40 | Maintains | Outperform | Get Alert |
| 07/19/2022 | NOVN | Buy Now | Novan | — | — | Jeff Jones35% | → $12 | Initiates | → Outperform | Get Alert |
| 07/18/2022 | CLRB | Buy Now | Cellectar Biosciences | $4.88 | 12.7% | Jeff Jones35% | → $5.5 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.24 | 7121.75% | Jeff Jones35% | → $17 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | EVAX | Buy Now | Evaxion Biotech | $2.38 | 572.27% | Jeff Jones35% | → $16 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | MBRX | Buy Now | Moleculin Biotech | $0.35 | 3913.76% | Jeff Jones35% | → $14 | Assumes | → Outperform | Get Alert |
| 07/18/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Jeff Jones35% | → $5.5 | Assumes | → Outperform | Get Alert |
| 06/09/2022 | PMVP | Buy Now | PMV Pharma | $1.24 | 2561.29% | Jeff Jones35% | $30 → $33 | Maintains | Outperform | Get Alert |
| 04/01/2022 | RAIN | Buy Now | Rain Oncology | $3.50 | 328.57% | Jeff Jones35% | → $15 | Initiates | → Outperform | Get Alert |
| 03/10/2022 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | 1594.92% | Jeff Jones35% | $30 → $20 | Maintains | Outperform | Get Alert |
| 03/02/2022 | PMVP | Buy Now | PMV Pharma | $1.24 | — | Jeff Jones35% | — | Upgrade | Perform → Outperform | Get Alert |
| 02/01/2022 | VTYX | Buy Now | Ventyx Biosciences | $2.04 | 1370.59% | Jeff Jones35% | → $30 | Initiates | → Outperform | Get Alert |
| 12/10/2021 | PLRX | Buy Now | Pliant Therapeutics | $1.29 | 3000.78% | Jeff Jones35% | → $40 | Initiates | → Outperform | Get Alert |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones35% | $35 → $50 | Upgrade | Perform → Outperform | Get Alert |
| 11/15/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones35% | — | Downgrade | Outperform → Perform | Get Alert |
| 10/05/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones35% | → $35 | Initiates | → Outperform | Get Alert |
| 08/19/2021 | PMVP | Buy Now | PMV Pharma | $1.24 | — | Jeff Jones35% | — | Initiates | → Perform | Get Alert |
| 05/07/2021 | CMMB | Buy Now | Chemomab Therapeutics | $1.18 | 3459.32% | Jeff Jones35% | → $42 | Initiates | → Outperform | Get Alert |
